McClements, 2020 - Google Patents
Enhancing efficacy, performance, and reliability of cannabis edibles: Insights from lipid bioavailability studiesMcClements, 2020
- Document ID
- 12463187227533231205
- Author
- McClements D
- Publication year
- Publication venue
- Annual review of food science and technology
External Links
Snippet
The legal sale of cannabis-enriched foods and beverages for medical or recreational purposes is increasing in many states and countries, especially in North America and Europe. These food-based cannabis delivery systems vary considerably in their …
- 230000036912 Bioavailability 0 title abstract description 49
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/30—Macromolecular compounds
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin, zein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| McClements | Enhancing efficacy, performance, and reliability of cannabis edibles: Insights from lipid bioavailability studies | |
| Sanidad et al. | Curcumin: recent advances in the development of strategies to improve oral bioavailability | |
| Mao et al. | Emulsion design for the delivery of β-carotene in complex food systems | |
| Light et al. | Emulsion, hydrogel and emulgel systems and novel applications in cannabinoid delivery: A review | |
| Choi et al. | Nanoemulsions as delivery systems for lipophilic nutraceuticals: strategies for improving their formulation, stability, functionality and bioavailability: SJ Choi, DJ McClements | |
| Sridhar et al. | Recent advances on nanoparticle based strategies for improving carotenoid stability and biological activity | |
| Velderrain-Rodríguez et al. | Encapsulation and stability of a phenolic-rich extract from mango peel within water-in-oil-in-water emulsions | |
| Gulotta et al. | Nanoemulsion-based delivery systems for polyunsaturated (ω-3) oils: formation using a spontaneous emulsification method | |
| Dasgupta et al. | Nanoemulsion ingredients and components | |
| Wu et al. | Nutraceutical delivery systems to improve the bioaccessibility and bioavailability of lycopene: A review | |
| Chen et al. | A review of recent progress in improving the bioavailability of nutraceutical‐loaded emulsions after oral intake | |
| Chen et al. | Potential of excipient emulsions for improving quercetin bioaccessibility and antioxidant activity: an in vitro study | |
| Zhou et al. | Food-grade systems for delivery of DHA and EPA: Opportunities, fabrication, characterization and future perspectives | |
| Rudzińska et al. | Liposomes as carriers of bioactive compounds in human nutrition | |
| Dasgupta et al. | An introduction to food grade nanoemulsions | |
| US20200170950A1 (en) | Compositions comprising a cannabinoid or a cannabis-derived compound, methods of making and use | |
| EP3716945A1 (en) | Liquid dosage forms, methods of making and use | |
| Keivani Nahr et al. | The colloidal and release properties of cardamom oil encapsulated nanostructured lipid carrier | |
| Borah et al. | Recent trends in valorization of food industry waste and by-products: encapsulation and in vitro release of bioactive compounds | |
| Maurya et al. | Vitamin C fortification: Need and recent trends in encapsulation technologies | |
| Abuhassira-Cohen et al. | Enhancing the bioavailability of encapsulated hydrophobic nutraceuticals: Insights from in vitro, in vivo, and clinical studies | |
| Dasgupta et al. | Food nanoemulsions: Stability, benefits and applications | |
| Jeong et al. | Effect of the emulsifier type on the physicochemical stability and in vitro digestibility of a lutein/zeaxanthin-enriched emulsion | |
| Zhou et al. | Research progress on natural bio-based encapsulation system of curcumin and its stabilization mechanism | |
| Lajoie et al. | Impact of emulsifiers for the nanoencapsulation with maltodextrin of cannabis oil by spray drying on the physicochemical properties and bioaccessibility of cannabinoids |